Categories: BUSINESS

Imitation weight-loss drugs boosted Hims & Hers. Executives cashed in.


Hims & Hers launched a pharmacy-made weight-loss drug last year, taking advantage of an FDA rule allowing it to temporarily make copies of Novo Nordisk’s semaglutide. The gambit boosted the telehealth firm’s stock price, and executives made millions selling shares.

Source link

freshblognews

Share
Published by
freshblognews

Recent Posts

How Google’s Antitrust Case Could Upend the A.I. Race

A federal judge issued a landmark ruling last year, saying that Google had become a…

14 minutes ago

National Security Adviser Mike Waltz to leave White House role, media reports

US National Security Adviser Mike Waltz is leaving his post with the Trump adminstration, according…

15 minutes ago

Fast, Easy Stir-Fried Shrimp Recipe

My husband’s current favorite dinner category is “spicy tomato seafood.” This, as you may well…

20 minutes ago

House Votes to Block California Plan to Ban New Gas-Powered Cars in 2035

The House on Thursday voted to bar California from imposing its landmark ban on the…

29 minutes ago

TEFAF New York Keeps Its Focus on the Classics In a Turbulent Time

Highlights at this year’s fair include a circa 1933 mask-shaped plaster sculpture by Alberto Giacometti,…

29 minutes ago

Couple travels to 197 countries, recounts best food, views and other favorites

Traveling internationally with a significant other is just a dream for some, but one couple…

37 minutes ago